Table 2 Detailed clinical and demographical profile of subjects (N = 250) included in the study.
S. No. | Category (n) | Mean Age (Yr) ± SD | Gender | HIV status | BCG Vaccination | Mantoux test | Smear | MGIT Culture (%) | MDR (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male (%) | Female (%) | Pos (%) | Neg (%) | Yes (%) | No/uk (%) | Pos (%) | Neg/uk (%) | Pos (%) | Neg (%) | |||||
1 | PTB (n = 111) | 35.0 ± 15.2 | 63 (56.8) | 48 (43.2) | 15 (13.5) | 96 (86.5) | 42 (37.8) | 69 (62.2) | 68 (61.3) | 43 (38.7) | 72 (64.9) | 39 (35.1) | 111 (100) | 46 (41.4) |
2 | EPTB (n = 29) | 31.0 ± 16.1 | 15 (51.7) | 14 (48.3) | 5 (17.2) | 24 (82.8) | 10 (34.5) | 19 (65.5) | 11 (37.9) | 18 (62.1) | 4 (13.8) | 25 (86.2) | 29 (100) | 4 (13.8) |
4 | HC (n = 50) | 30.0 ± 13.2 | 30 (60.0) | 20 (40.0) | 0 | 50 (100) | 14 (28.0) | 36 (72.0) | — | 50 (100) | 0 | 50 (100) | 0 | 0 |
5 | DC (non-TB) n = 60 | 31.4 ± 14.6 | 34 (56.7) | 26 (43.3) | 20 (33.3) | 40 (66.7) | 18 (30.0) | 42 (70.0) | — | 60 (100) | 0 | 60 (100) | 0 | 0 |
Total | 250 | 31.8 ± 14.8 | 142 (56.8) | 108 (43.2) | 40 (16.0) | 210 (84.0) | 84 (33.6) | 166 (66.4) | 79 (31.6) | 171 (68.4) | 76 (30.4) | 174 (69.6) | 140 (56.0) | 50 (20.0) |
